Data as of Mar 07
| -0.12 / -0.25%|
STERIS Corp. is engaged in the provision of infection prevention and other procedural products and services, focused on healthcare, pharmaceutical, and research industries. It operates through the following segments: Healthcare, Life Sciences, and STERIS Isomedix Services. The Healthcare segment manufactures and sells infrastructure capital equipment and accessory; and provides consumable, information support, and service solutions.' 4th sentence, may be written as. 'The Life Sciences segment serves pharmaceutical manufacturers and research organizations by providing decontamination and sterilization technologies, products and services. The Life Sciences segment serves pharmaceutical manufacturers and research organizations by providing decontamination and sterilization technologies, products and services that help support the safety and effectiveness of the products they produce. The STERIS Isomedix Services segment provides ethylene oxide and/or irradiation services on a contract basis through a network of facilities in North America. The company was founded by Raymond Kralovic and Ed Schneider in August 9, 1985 and is headquartered in Mentor, OH.
|Walter M. Rosebrough||President, Chief Executive Officer & Director|
|David Allen Johnson||SVP-Global Operations & Quality|
|Michael J. Tokich||Chief Financial Officer & Senior Vice President|
|Peter A. Burke||Chief Technology Officer & Senior Vice President|
|Robert E. Moss||SVP & Group President-Isomedix Services|